文献速递免疫规划传染病防控与疫情报告

基于病毒样颗粒的口蹄疫与塞内卡谷病毒A多病原疫苗在小鼠和猪中诱发均衡而广泛的保护效力

Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs.
PubMed 文献 · Vaccine · 2024-05-06

研究开发了由三种病毒样颗粒组成的口蹄疫病毒O型、A型与塞内卡谷病毒A联合疫苗,在小鼠和猪中诱发了与各自单价疫苗相当的抗原特异性血清抗体应答,免疫血清对三种病毒的中和滴度与单价疫苗相当,在猪中可抵御口蹄疫病毒A型、O型及塞内卡谷病毒A的单一致病或混合感染,而单价疫苗仅能保护同源病毒感染。

要点

  • 三价病毒样颗粒联合疫苗在小鼠和猪中诱发了与单价疫苗相当的抗原特异性血清抗体应答。
  • 联合疫苗免疫血清对口蹄疫病毒A型、O型和塞内卡谷病毒A的中和滴度与单价疫苗相当。
  • 联合疫苗免疫猪血清可抵御口蹄疫病毒A型、O型及塞内卡谷病毒A的单一致病或混合感染,单价疫苗仅保护同源病毒。

核心结论

  • 研究提出了一种针对口蹄疫与塞内卡谷病毒A的联合疫苗候选,并为其他猪病毒病联合疫苗开发提供新思路。

研究设计与样本

  • 研究构建了由三种病毒样颗粒组成的联合疫苗,分别靶向塞内卡谷病毒A及口蹄疫病毒O型和A型,并在小鼠和猪中评估免疫原性与保护效力。

主要发现

  • 三价病毒样颗粒疫苗诱发了抗原特异性且强健的血清抗体应答,与各自单价疫苗所诱发的应答相当。
  • 联合疫苗免疫血清对A型、O型口蹄疫病毒和塞内卡谷病毒A均呈强中和,中和滴度与单价疫苗相当,提示三种病毒样颗粒组分间免疫原性兼容性高。
  • 联合病毒样颗粒疫苗免疫猪血清对A型、O型口蹄疫病毒和塞内卡谷病毒A的单一致病或混合感染提供有效保护。
  • 单价疫苗仅能保护猪免受同源病毒感染,不能抵御异源攻击。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inactivated vaccines lack the capability to serologically differentiate between infected and vaccinated animals, thereby impeding the effective eradication of pathogen. Conversely, vaccines based on virus-like particles (VLPs) emulate natural viruses in both size and antigenic structure, presenting a promising alternative to overcome these limitations. As the complexity of swine infectious diseases increases, the increase of vaccine types and doses may intensify the stress response. This exacerbation can lead to diminished productivity, failure of immunization, and elevated costs. Given the critical dynamics of co-infection and the clinically indistinguishable symptoms associated with foot-and-mouth disease virus (FMDV) and senecavirus A (SVA), there is a dire need for an efficacious intervention. To address these challenges, we developed a combined vaccine composed of three distinct VLPs, specifically designed to target SVA and FMDV serotypes O and A. Our research demonstrates that this trivalent VLP vaccine induces antigen-specific and robust serum antibody responses, comparable to those produced by the respective monovalent vaccines. Moreover, the immune sera from the combined VLP vaccine strongly neutralized FMDV type A and O, and SVA, with neutralization titers comparable to those of the individual vaccines, indicating a high level of immunogenic compatibility among the three VLP components. Importantly, the combined VLPs vaccines-immunized sera conferred efficient protection against single or mixed infections with FMDV type A and O, and SVA viruses in pigs. In contrast, individual vaccines could only protect pigs against homologous virus infections and not against heterologous challenges. This study presents a novel combined vaccines candidate against FMD and SVA, and provides new insights for the development of combination vaccines for other viral swine diseases.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Song H, Waheed Abdullah S, Yin S, et al. Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs. Vaccine. 2024. PMID: 38714448. doi:10.1016/j.vaccine.2024.04.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。